AbbVie Inc. (NEO:ABBV)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of CAD 575.29 billion. The enterprise value is 663.88 billion.

Market Cap	575.29B
Enterprise Value	663.88B

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	73.76%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 175.90 and the forward PE ratio is 16.97.

PE Ratio	175.90
Forward PE	16.97
PS Ratio	6.92
PB Ratio	-158.91
P/TBV Ratio	n/a
P/FCF Ratio	20.98
P/OCF Ratio	19.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.86, with an EV/FCF ratio of 24.21.

EV / Earnings	202.99
EV / Sales	7.94
EV / EBITDA	15.86
EV / EBIT	22.28
EV / FCF	24.21

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.50%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.50%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	1.51M
Profits Per Employee	59,464
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-1.02B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.80% in the last 52 weeks. The beta is 0.35, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+35.80%
50-Day Moving Average	31.78
200-Day Moving Average	28.67
Relative Strength Index (RSI)	60.37
Average Volume (20 Days)	15,677

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.37

Income Statement

In the last 12 months, AbbVie had revenue of CAD 83.08 billion and earned 3.27 billion in profits. Earnings per share was 1.84.

Revenue	83.08B
Gross Profit	59.37B
Operating Income	29.62B
Pretax Income	2.31B
Net Income	3.27B
EBITDA	41.12B
EBIT	29.62B
Earnings Per Share (EPS)	1.84

Balance Sheet

The company has 7.90 billion in cash and 95.90 billion in debt, giving a net cash position of -88.00 billion.

Cash & Cash Equivalents	7.90B
Total Debt	95.90B
Net Cash	-88.00B
Net Cash Per Share	n/a
Equity (Book Value)	-3.62B
Book Value Per Share	-2.08
Working Capital	-15.12B

Cash Flow

In the last 12 months, operating cash flow was 29.06 billion and capital expenditures -1.64 billion, giving a free cash flow of 27.42 billion.

Operating Cash Flow	29.06B
Capital Expenditures	-1.64B
Free Cash Flow	27.42B
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

AbbVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	481.49%
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	0.57%
FCF Yield	4.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7